°Q½×°Ï>ªYÄ£¥ÍÂå
¥«³õ­º¨£·sÃÄ ±ÂÅv½Í¤¤
·|­û:hung1201 10149413 µoªí®É¶¡:2020/6/24 ¤U¤È 02:11:23
¥«³õ­º¨£·sÃÄ(¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸) Àø®Ä¤ÀªR p=0.009

6634 ªYÄ£

ªÑ¥»: 3.832»õ

¥D­n·~°È:

¨xŦ¯e¯fªvÀø¤Î¯kµhªvÀø¬ÛÃöÃĪ«¬ã¨s¤Î¶}µo

¸³ºÊ«ùªÑ¤ñ¨Ò: 21.7%(¼W¥[¤¤)

¥~¸ê«ùªÑ¤ñ¨Ò: 0.22%(¼W¥[¤¤)

Ä~Äò©¹¤U¬Ý...!

=============================================================================

²£«~01¡GSNP-610 (ªvÀø¯×ªÕ¨x¯e¯f·sÃÄ)

¾AÀ³¯g: «D°sºë©Ê¯×ªÕ¨xª¢

²£«~Àu¶Õ:

1.¥Ø«e©|µL¼Ð·ÇªvÀøÃĪ«

2.¥«³õ­º¨£·sÃÄ(First-in-class)

3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x

4.µL¦w¥þ©Ê°ÝÃD

¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C

Ävª§¤O:

1.¦h­«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢

2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A­°§C¨x¯×

3.¥i´£¥X¨uÃĥӽСAÀ³¥Î©óªvÀø§³®W«æ©Ê¯×ªÕ¨x

¬ãµo¶¥¬q:

1.¤w³q¹LUSFDA¤ÎTFDA¼f¬d¶i¤JÁ{§É¤G´Á

2.Á{§ÉÀø®Ä¤Î·sªvÀø¾÷ÂàÅçÃÒ

Àø®Ä¤ÀªR¡G

1.²Ä¤@´ÁÁ{§É¸ÕÅç¡Gµ²ªGÅã¥Ü¤HÅé¨Ï¥Î¦w¥þ¡A©Ê½è¨}¦n

2.²Ä¤G´ÁÁ{§É¸ÕÅç¨ä¤¤¤ÀªR¡G17¦ìNASH ¯f¤H (p=0.009)

=============================================================================

²£«~02¡GSNP-630

¾AÀ³¯g:«D°sºë©Ê¯×ªÕ¨xª¢

²£«~Àu¶Õ:

1.¬°Àu¤Æ(Optimized)¤§·s¤Æ¾Ç¹êÅé(NCE)

2.¥«³õ­º¨£·sÃÄ(First-in-class)

3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x

4.§@¬°²Ä¤@¥N²£«~¤W¥««áªº±µÄò¦û¦³¥«³õ¤§²£«~

¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C

Ävª§¤O:

1.¦h­«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢

2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A­°§C¨x¯×

3.Àu¤ÆªºÀø®Ä±j«×¡B§@¥Î®É¶¡

4.µL¦w¥þ©Ê°ÝÃD

¬ãµo¶¥¬q:

1.Á{§É«e

2.¹w©w¥Ó½Ð¬ü°êFDAIND¡B§Ö³t³q¹D(fasttrack)¡C

3.¥Ó½Ð¬ü°ê¬ð¯}©ÊªvÀø(breakthrough therapy)ªº»{©w¡C

Àø®Ä¤ÀªR¡G

1. ¥Ø«e¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.05

=============================================================================

²£«~03¡GSNP-810 (µL¨x¬r©Ê¤îµh·sÃÄ¡B¸Ñ¬r¾¯)

¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃÄ (¸Ñ¼öÂíµh¾¯)

²£«~Àu¶Õ:

1.¦w¥þ¤Æ¦Xª«·s²Õ¦X¡BµL¨x¬r©Ê

2.¸Ñ¨M­¢¤ÁÂåÀø»Ý¨D (Important urgent unmet medical needs)

3.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y¥i¼W¥[¾¯¶q

¥«³õ: ¤AñQÓi×ô¶È¦b¬ü°ê¤@¦~´N¦³40»õ¬ü¤¸ªº¥«³õ

Ävª§¤O:

1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«

2.¥i§ð¦û¼s¤j¥«³õ¡]NSAID, COX-2 §í¨î¾¯¡BOpioidsÃþ¤îµhÃÄ¥«³õ¡^

3.¥i¬Ù°£¶D³^¶O¡B±Ð¨|°V½m¶O

¬ãµo¶¥¬q:

1.¤w§¹¦¨§C¾¯¶q¡B°ª¾¯¶qÁ{§É¸ÕÅç

2.¤w¥Ó½ÐUSFDA¼Ï&#32445;Á{§É¸ÕÅç¡B±N¥Ó½Ð¬ð¯}©Ê¼f¬d/§Ö³t³q¹D

3.µL¨x¬r©Ê¤AñQÓi×ô¸Ñ¬r¾¯¦¨¤À¡A¤w¥Ó½Ð¬dÅçµn°O¥Î¤§Á{§É¸ÕÅç

=============================================================================

²£«~04¡GSNP-830/ SNP-840

¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃĽƤè(ªvÀø¤¤¡B­««×¯kµh)

²£«~Àu¶Õ:

1.µL¨x¬r©Ê¤AñQÓi×ôªº½Æ¤è

2.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y¡A¥i¼W¥[¾¯¶q

¥«³õ: ¤AñQÓi×ô³B¤èÃĦb¬ü°ê¤@¦~´N¦³27»õ¬ü¤¸ªº¥«³õ

Ävª§¤O:

1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«½Æ¤è

2.½Æ¤è¤w¥Ñ¬ü°êFDA­n¨D­°¾¯¶q§C©ó325²@§J¡A±N¼vÅTÀø®Ä

3.¦³¨Ï¥Î±M§Q¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y

4.¥i¼W¥[¤AñQÓi×ô¾¯¶q

¡]¥Ñ325mg ¦^´_¦Ü500 mg¬Æ¦Ü§ó°ª¡A·|¸û¦³®Ä¡^¥H¼W¥[Àø®Ä¡A©Î´î¤ÖOpioids¾¯¶q¡A­°§C¦¨Å}°Æ§@¥Î

5.¤GªÌ¾Ü¤@±ÂÅv

6.¥i¼W¥[¥«¦û²v

¬ãµo¶¥¬q:

1.SNP-810¨ú±oÃÄÃÒ«á¡A¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê¸ÕÅç

SNP-830 ¤£¬O ·s¦¨¤À ªº·sÃÄ¡A©Ò¥H¤£»Ý­n¶i¦æ²Ä¤@¡A¤G¤Î¤T´ÁÁ{§É´úÅç

µ¥ SNP-810 ®³¨ìÃÄÃÒ«á¡A¥H ·sÀø®Ä½Æ¤è¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê´úÅç ´N¥i¥HÀò±oÃÄÃÒ

=============================================================================

*****************************************************************************

SNP-8 ¨t¦C Àø®Ä¤ÀªR¡G

1. ¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005

1. ¤w¸g§¹¦¨¤§¤HÅé¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005

=============================================================================

*****************************************************************************

¥¼¨Ó¥Ø¼Ð±ÂÅv¥D¤O²£«~¡G

1. ¯×ªÕ¨xÃÄ¡GSNP-610 ©M SNP-630 ¦U¦³ÀuÂI¡A¥Ø¼Ð¬°¥þ²y±ÂÅv

2. ¤îµhÃÄ(OTC): SNP-810, ¥Ø¼Ð¬°¬ü°ê¤Î¥þ²y±ÂÅv

3. ¤îµhÃÄ(³B¤èÃÄ): SNP-830 ¤Î SNP-840, ¦b°Êª«¤W¬Ò¦³¥¿­±ªºµ²ªG¡A¥Ø¼Ð¬°¥þ²y±ÂÅv

=============================================================================

*****************************************************************************

¥Ø«e¤½¥q»P°ê»Ú¤j«¬Ãļt¥¿¦b½Í§Þ³N±ÂÅv©M¦X§@­p¹º

§Ú¬Ý¹L¤½¥q©xºô©M©Ò´£¨Ñªº¸ê®Æ¡Aı±o¤½¥q«Ü¥Î¤ß¦b¸gÀç¡A¦Ó¥B¸ê®Æ¤]«Ü¸Ô²Ó

¹ï¤½¥qµo®i«Ü¦³¦Û«H¡A¥¼¨ÓªÑ»ù­È±o´Á«Ý¡A¦³¾÷·|¬O ¤U¤@­Ó ¦X¤@ ÄÆªÑ

-----------------------------------------------------------------------------

¥H¤W¸ê®Æ ³£°Ñ¦Ò ªÑªF·|ij¨Æ¿ý.pdf ©M ¤½¥q©xºô (¦³¿³½ìµÛÅwªï¦A²`¤J¬ã¨s»P°Q½×)

·|­û:ROGER588910148151µoªí®É¶¡:2023/2/3 ¤U¤È 01:21:24²Ä2834½g¦^À³
2022.11.27¤¤°ê¯«¸g¬ì¾Ç¾Ç·|²Ä¤Q¤­©¡¥þ°ê¾Ç³N·|ij¤¤°ê¯«¸g¬ì¾Ç¾Ç·|²Ä¤Q¤­©¡¦~·|

www.cns.org.cn/2022/cn-program07.php

P-496 CYP2E1¦bMPTP»¤¾Éªº©¬ª÷´Ë¯f¤p¹«¼Ò«¬¤¤ªº§@¥Î¬ã¨s

----------------------------------------------------------------------------------------------

CYP2E1¹vÂI·|¤£·|¶V¨Ó¶V¼ö¾x???

·|­û:ROGER588910148151µoªí®É¶¡:2023/2/3 ¤U¤È 01:07:21²Ä2833½g¦^À³
2023.1.19 ¼w°ê­ì³Ð¬ã¨s¤å

www.frontiersin.org/articles/10.3389/fphar.2022.1094265/full

¤@¶µ CYPome ½d³ò¤ºªº¬ã¨s´¦¥Ü¤F©¬ª÷´Ë¯fµo¯f¾÷¨î¤¤ªº·s¼ç¦b°Ñ»PªÌ

...¨ì¥Ø«e¬°¤î¡A¥u¦³CYP2D6©MCYP2E1¤¤ªº SNP¡]³æ®Ö苷»Ä¦hºA©Ê¡^»P PD(©¬ª÷´Ë¤ó¯f)ªº©ö·P©Ê¦³Ãö¡C

...ªí©ú³o¨Ç P450 ¬O PD µo¯f¾÷¨î¤¤ªº·s¼ç¦b°Ñ»PªÌ¡C­º¦¸µo²{²§±`°ªªº OR ­È¡]°ª¹F 12.9¡^¡C³o±N¾É­P¹ï PD ªº°_·½©Mµo®i¦³§ó²`¤Jªº¤F¸Ñ¡A¨Ã¥i¥Î©ó¶}µo°w¹ï¸Ó¯e¯fªº­P¯fªvÀøªº·sµ¦²¤¡C

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/7/23 ¤U¤È 10:56:57²Ä 2257 ½g¦^À³

¥Ñª¢¯g¤¶导ªºCYP2E1ªº变¤Æ¦b[¨x]内ªº调±±Éó¨î¤w较为©úÚÌ¡A¦ý¬O对[¤¤枢内] CYP2E1ªº变¤Æ±¡úG¬ã¨s较¤Ö¡C

...

¬ã¨s´£¥Ü¡A©¬ª÷´Ë¯f¡Bªüûدý®üÀq¯f¡B¦h发©Êµw¤Æ¡B¦Ùµä缩侧¯Áµw¤Æ¯gµ¥¯«经°h¦æ©Ê¯e¯fªº¯f²z¥Í²z学§ï变ÉO«ù续ªºª¢¯g¤Ï应过µ{±K¤Á¬Û关[1-3]¡AµM¦Ó¨ä¯f²zÉó¨î©|»Ý²`¤J¬ã¨s¡C

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/7/23 ¤U¤È 10:48:06²Ä 2256 ½g¦^À³

ªñ¦~¨Ó¡A²Ó­M¦â¯À P450 酶 (CYP) ªº­«­n©Ê¤w¶W¥X¨ä¦b¨xŦ¤¤ªº§@¥Î???

CYP2E1 ¬O¤@ºØ¤½»{ªº°Ñ»P¦UºØ¤º·½©Ê©M¥~·½©Êª«½è¥NÁªº³æ¥[®ñ酶¡A¦b¯A¤Î©¬ª÷´Ë¯fµo®iªº¤j¸£¤¤°_µÛ¦ÜÃö­«­nªº§@¥Î¡C

CYP2E1ªº [¹Lªí¹F]¦ü¥G¹ï¦h¤ÚÓi¯à¯«¸g¤¸¦³®`....

·|­û:¦V«e¦æ10140498µoªí®É¶¡:2023/2/3 ¤U¤È 12:26:00²Ä2832½g¦^À³
¼á²M¤@¤U

810¬ü°êOTCÃÄÃÒ¤£¬O¨S»ù­È

³q¸ô¦æ¾P¡B¼s§i«Å¶Ç¶O¥ÎÅå¤H

¤£¬OªYÄ£¥i¥H­t¾á±o°_

¥B¤]¤£¨£±o·|½æ±o¦n

¥u­n±ÂÅvµ¹¤j¼t

¥u­n1®a¦æ¾P¤AñQÓi×ô¤îµhÃÄ¥´µÛ¡uµL¶Ë¨x¡v

¨ä¥L¼t°Ó·|³Q­¢¸ò¶i

810³B¤èñÃÄÃÒ¦¨¥\

´N·¥¦³¥i¯à¥þ¦Y³B¤èñ¥«³õ

¥i§O§Ñ¤F¡A°ª¹F4-8§Jªº³B¤èñ¡I

¥þ¥@¬É¶È¦¹¤@®a

§OµL¤À¸¹

³o¶ô¤j»æ¤~¬O¿W¨¤Ã~

¦pªG610-2bÃĮķ¥ÅãµÛ

«h¤S¬O¥t¤@­Ó¿W¨¤Ã~

·|­û:¦V«e¦æ10140498µoªí®É¶¡:2023/2/3 ¤W¤È 08:48:34²Ä2831½g¦^À³
¤j®a¤@°_°Q½×¡A§â­Ó¤H¤£¦P¬Ýªk´£¥X¡A¦h»PªÅ³£°Q½×¯uªº«Ü¦n¡C

¨È瑡±d·íªì¦³µo¦æADR¡A«á¦]¸ÕÅç¼Æ¾Ú¤£¨Î¡AªÑ»ù¶^¨ì¦U¦ì¼Æ¡A«á¨Ó±q»O¤U¥«¡AªÑ²¼5´«1¥þ¼ÆÂରADR¡A³Ì°ªªÑ»ùªñ10¬ü¤¸¡A¥Ø«e0.7¡A©Ò¥H®Ú¥»ÁÙ¬O¦b¡uÃĮġv¡C

¥ý¸òR¤j­Pºp¡A¤£¬O¸ò±z¥´ºj¡A·í±z±ÀÂˤߤë®É¥»¨Ó­n´£¿ô±z¡A¡u°ò¥»­±¡v¦³°ÝÃD¡H¦ý¤S©È¦Û¤v¬Ý¿ù´N¸T¨¥¡C

§Ú±q2¦Ê¤¸ªº¤ß¤ë¬Ý¨ì¤£¦bª©¤W¡A¦³¥y«D±`­«­nªº¸Ü¡u¬OÃĮġHÁÙ¬O¦w¼¢¾¯®ÄÀ³¡A­n¸ò¥DºÞ¾÷Ãö·¾³q¡v¡A³o¥y¸Ü§Ú±À¦ôÃĮĤ£©úÅã¡I¦³¨S¦³¬Ý¹L¸Ó¤½¥q¤½§i¥ô¦ó¸ÕÅçP­È¦h¤Ö¡H¸ÕÅç¹Lµ{¶i«×½½¤û¨B¡A¾ÇªÌ¸³¥J±j½Õ2±iBTD³Ì¤Ö­È2¦Ê¡A¯u¦³ÃĮġA¦ÛµM¦³¤H®¼¼W¸êÄ~Äò¿N¿ú¡C

¥_·¥¿³«e¸³ÁpÃĤõ¤O¥þ¶}¡A¿N¿ú¿N¨ì¨S¤H¤ä«ù¡A¥u¦]¨S¦³¦¨ÁZ¥X¨Ó¡A«á¨Ó´«¤j©@¶i¨Ó¡A¦¨¥\¤F¤@ÃÄ¡A¥«­È¶W¹L7¦Ê»õ¡C

­Ó¤HÃÙ¦¨R¤j¬Ýªk¡AOTCÃÄÃÒ¤£­È¿ú¡A¥u¬O°µ¬°ÃĤޡA810­n­È¿ú´N¬O³B¤èñÃÄÃÒ¡A¤~¯à½Í¨ì¦n±ø¥óªº±ÂÅv¡C¦pªG¥H°Ó·~¨¤«×¨Ó°µ¸ÕÅç¡A¦­´N§¹¦¨¼Ï¶s¸ÕÅç¤F¡C

­Ó¤H²q´ú¡A±ÂÅv®É¾÷¤]¬O¦bµ¥³B¤èñÃÄÃÒ¡A¦P®É¤]¬OIPOªº®É­Ô¡C

610-2b¦pªGµ²ªG¥X¨Ó¡A¤]¹³2a¤@¼ËÀu¡A¦U¦ì¤j¤j´N¤j¥i©ñ¤ß¤F¡A°µ¤£°µ3´Á³£¨SÃö«Y¡I¦Û¦³¤j©@¤Wªù´£¿Ë¡C·|¤£·|¤ñ»ù´N·|´¦¾å¡I

¦³¥y­@¤H´M¨ýªº¸Ü¡u¡K¡K.´N¨ì¬ü°ê¤W¥«¡v

·|­û:¤g¾|µf10147850µoªí®É¶¡:2023/2/2 ¤U¤È 07:06:37²Ä2830½g¦^À³
´£¥X¤@¨Ç§Úªº¬Ýªk:

1.¯Ê¸êª÷? ¥Î$100²{ª÷¼W¸ê500¸UªÑ´N¥i¶Ò¶°5»õ¤¸, 1000¸UªÑ«h¥i¶Ò¶°10»õ. 6919¦b2021¸êª÷¬y«D±`¦M«æ. ´N¥H$120 ¼W¸êÀò±o¤@µ§¸êª÷. µM«á¥[³t¦U¶µ§G§½. ·í®É6919Á{§É2³£ÁÙ¤~­è¶}©l. ²{¦b6434¥H$100²{¼WÀ³¸Ó¤£Ãø.

2.¤£¥Î¥h¨º«ü¤W¥«, Ãm¤é¶O®É.¥ý­n¥xÆW¤U¥«¦A¥h¬ü°ê¥Ó½Ð. ¦pªG±ÂÅv½Í¦¨,¦b¥x¤WÂd¤]¥iÁ`¥«­È»á°ª. ½Í¤£¤U±ÂÅv,¥xÆW¨S¦æ±¡¬ü°ê¤]¤W¤£¥h. ¥ý§â¤@¶µ²£«~±ÂÅv½Í¤U¨Ó³Ì­«­n.

§Úı±o¤½¥q³Ì¤j°ÝÃD¦b©ó: ¤£°÷focus¤Î¥ø¹Ï¤ß¤£°÷. ³o¤]¬O§Ú»{¬°¤£­n´Á«Ý±ÂÅv°¨¤W½Í¤U¨Ó. §Ú¬O¥ý¦ô1¦~«á. ¦Ü©ó±ÂÅvª÷ÃB. ¬Ý¦X¤@ªº5.3»õ¬üª÷, ¤Î±dè®6919 ªº¹w´Á6-8.8»õ¬üª÷. §Ú»{¬°À³¸Ó¦³5»õ¬üª÷¥H¤W.

¥H±ÂÅvª÷ÃB,ªÑ¥»; ¥H¤ÎÆp¥Û°òª÷­n§ß´Ó6634¦¨¬°¿W¨¤Ã~ªº·NÄ@. §Ú¬O¥´ºâ«ùªÑ2-3¦~, ¥Ø¼Ð»ù400-500.

¥H¤W¥u¬O­Ó¤H¬Ýªk. ºCºC¶R¶i. ­n¬O´£«e±ÂÅv¦¨¥\, ªÑ»ù¦b§Ú©|¥¼§G§½§¹¦¨´N¤jº¦. ¤]«Ü¦nÁÙ¬O¦³ÁȨì.

·|­û:¯È¤W´I¶Q10134993µoªí®É¶¡:2023/2/2 ¤U¤È 05:22:19²Ä2829½g¦^À³
¤ß®®¬O±Ñ¦b°]ª«

¦ý±Ñ¦b°]°Èªº­ì¦]¬O®³¤@¤j°ï¿ú¥h·d¤ß«aÃÄ

¦Ü©óªYÄ£ªº¹vÂI¥D¬y«D¥D¬y°ÝÃD

§Ú·Q­«ÂIÁÙ¬OÃĮħa ¦pªGÃÄ®ÄÀu©óm¼t ÁÙ¬O«D±`¦³»ù­Èªº

·|­û:ROGER588910148151µoªí®É¶¡:2023/2/2 ¤U¤È 04:22:53²Ä2828½g¦^À³
·|­û¡GNtumgk10151447 µoªí®É¶¡:2023/2/2 ¤U¤È 04:05:07²Ä 2826 ½g¦^À³

¦¶³Í¥Áªí¥Ü¡A¥Ñ©ó¦³®ÄÃIJzªº¥D¦¨¤À¨S¦³§ïÅÜ¡A­Y¦¨¥\±NSNP-810±ÂÅvµ¹¥Ø«e¾P°â¤AñQÓi×ô¦¨¤À¤îµhÃĪº¤j¼t¡A¤£¥Î­«·s°µÁ{§É¥Ó½ÐÃÄÃÒ¡A¥u»Ý­n§ó§ï¥]¸Ë¤Î¥é³æ¡A´N¯à¥H³Ì§Öªº³t«×¾P°â¶i¶¥ª©¡]¤£¶Ë¨x¡^²£«~¡C

------------------------------------------------------------------------------------------------

¦¶Á`ªº»¡©ú¬O«üOTC¥«³õ(«D³B¤è)¡C

¦ÓSNP-810±ÂÅv·|¬O2­Ó°Ï¶ô¥[Á`:«D³B¤è + ³B¤èÃÄ(­nÁ{§É¸ÕÅç)--³oºØ±¡ªp¤ñ³æ¯Âªº·sÃıÂÅvÁÙ½ÆÂø!

¤ß®®¬O§¹±Ñ¦b°]°È­±¡A«DÃĪ«¡C

·|­û:op123410143906µoªí®É¶¡:2023/2/2 ¤U¤È 04:15:37²Ä2827½g¦^À³
·PÁÂNt¤jªº¤À¨É¡G

¥h¬Ý¬Ý¤ß®®³Ì«á¸¨¨ì¤U¿³Âd¡A²{¦b¦b¥¼¤W¥«¡C

©Ò¥H¦¶¸³¨Æªø»¡ªºªñ´Á·|±ÂÅv¡H

¦³¤Hª¾¹D¶Ü¡H

·|­û:Ntumgk10151447µoªí®É¶¡:2023/2/2 ¤U¤È 04:05:07²Ä2826½g¦^À³
¦¶³Í¥Áªí¥Ü¡A¥Ñ©ó¦³®ÄÃIJzªº¥D¦¨¤À¨S¦³§ïÅÜ¡A­Y¦¨¥\±NSNP-810±ÂÅvµ¹¥Ø«e¾P°â¤AñQÓi×ô¦¨¤À¤îµhÃĪº¤j¼t¡A¤£¥Î­«·s°µÁ{§É¥Ó½ÐÃÄÃÒ¡A¥u»Ý­n§ó§ï¥]¸Ë¤Î¥é³æ¡A´N¯à¥H³Ì§Öªº³t«×¾P°â¶i¶¥ª©¡]¤£¶Ë¨x¡^²£«~¡C

R¤j¥ª¬Ý¥k¬Ý³£¤£¹³³B¤èÃÄ¡C

¦P·NÂù¹vÂI¡A¦ý¤´«D¥D¬y¡A­J±Ð±Â»¡¦h¾÷Âà§Ú¤]»{¦P¡C§Úªº½×ÂI¬O­Y¹L¥÷®³M¤½¥q©Î¨ä¥L¤½¥q¤ñ»ùªYÄ£¨ü¶ËªºÁÙ¬O¦U¦ìª©¤Í¡C¤Å§Ñ¤ß®®«e¨®¤§Å²¡C

·|­û:ROGER588910148151µoªí®É¶¡:2023/2/2 ¤U¤È 04:03:09²Ä2825½g¦^À³
www.facebook.com/linkingpros/videos/3194947797458964/

¼v¤ù8¤À~

­JP:....§Úªº»ù¿ú¨S¦³¤ñpanadol¶Q³á...¤]¨S¦³¤ñTylenol¶Q³á.....

------------------------------------------------------------------------------------

SNP-810¸Ñ¨M¤FAPAP¨x¬r©Ê¡A»ù¿ú¤´¥i«K©y!

·|­û:ROGER588910148151µoªí®É¶¡:2023/2/2 ¤U¤È 03:53:17²Ä2824½g¦^À³
SNP-6¡uÀø®Ä¦w¥þ©Ê¡v¸ûÀu?

www.facebook.com/watch/?v=3194947797458964

1.­JP¦³±j½Õ¬O[¤G´Á¹ï¤G´Á]µ²ªG¡C

2.6¨t¦C¬OÂù¹vÂI:CYP2E1 »P DGAT1¡C

3.­Ó¤H¤£­t³d»{¬°SNP-810±ÂÅv»ù­È¤£¦b«D³B¤èÃÄOTC¡A¦Ó¦b³B¤èÃÄ¥«³õ¡C

·|­û:op123410143906µoªí®É¶¡:2023/2/2 ¤U¤È 03:51:06²Ä2823½g¦^À³
Nt¤j¡G¨Ì±zªº¬Ýªk¡]¤À¨É¡^¡A³o¤@ÀÉ´N¤£¯à§ë¸ê¡H

¦n¹³¨S¦³¥¼¨Ó¡H

·|­û:Ntumgk10151447µoªí®É¶¡:2023/2/2 ¤U¤È 03:38:42²Ä2822½g¦^À³
­Ó¤HÁö¦³§ë¸êªYÄ£¡A¦ý¤£·|¤@¬N§j±·¡CªYÄ£6¨t¦C½T¹ê¦³¼ç¤O¡A¦ýªYÄ£µ´¹ï¨S¦³¿ú°µ¤T´Á¡AM¤½¥qÀH«K¼W¸ê³£¬O¦Ê»õ¥x¹ôµ¥¯Å¡A¥xÆWªº·sÃĤ½¥q´N¬O¨S¿ú¡A¤£¯à¤ñ·Ó°ê¥~¤½¥q¡C¥h¬ü°ê±¾µP·í§@¬Oª±¯º¸Ü§a¡A¤d¸U§O·í¯u¡C6¨t¦C°ê»Ú±ÂÅv¤]¬O±oµ¹¥X¼Æ¾Ú¡A¤×¨äDGAT«D¥D¬y¹vÂI¡A¤S¦³¦h§l¤Þ¤H©O?610¤G´Á­n§j¼N¦h¤[¡A§â§ó¦h¼Æ¾Ú®³¥X¨Ó¤~¦³¥Î¡C

8¨t¦C±ÂÅvª÷ÃB§Ú¤]¨S¦³¼ÖÆ[¨ì¤W¬Ý5»õ¬ü¤¸¡Apublic health ÃļtÄ@·N¥I¦h¤Ö¿ú©O? OTCÃĨS³q¸ô¡A¨S¼s§i = 0 »ù­È

­n¨ú¥N´¶®³¯k§¹¥þ¬O¦b§@¹Ú¡C

·|­û:¦V«e¦æ10140498µoªí®É¶¡:2023/2/2 ¤U¤È 03:28:10²Ä2821½g¦^À³
¤½¥q®i±æ»¡©ú·|:SNP-6¡uÀø®Ä¦w¥þ©Ê¡v¡uÀu¡v©ó«eªuªºMadrigal MGL-3196

R¤j

³o´N¬O§Ú©Ò»¡ªº¡u³o¼Æ¾Ú¦pªG¬O¯uªº¡v

M¤½¥qªÑ»ù¦³¶]¨ì310¬ü¤¸

ªYÄ£¥Ø«e¬O3¬ü¤¸¦h

­è¦n¬O¤H®a§À¼Æªº¹sÀY

³sC¤½¥q¶i«×¸¨«áªYÄ£¡A³£¦³11¬ü¤¸¡C

ÁÙ¬O¨ì¨º´µ¹F§J¤W¥«§a¡I

·|­û:½²ºû¤¯10143700µoªí®É¶¡:2023/2/2 ¤W¤È 09:59:56²Ä2820½g¦^À³
ªYÄ£¬Ý¨Ó¬O«eµ{¦üÀA¡I¡q¥HÃľiÃÄ¥[³t«e¶i¡r¡I¡F810¥[Á`³Ì¤Ö¤]¦³5»õ¬ü¤¸±ÂÅv¡A±ÂÅv«á«Ü§Ö´N¦³¤À¼íª÷¶i±b¡A¤£­n»¡²{ª÷º¡º¡¦Ü¤Ö¸êª÷«D±`¥R¨¬¡I6¨tµ¹¥¦½Ä3´Á´N¹ï¤F¡I3´Á­Y¶¶§Q®³¤U¡A¦æ±¡´N­¸¤Ñ¡I
·|­û:ROGER588910148151µoªí®É¶¡:2023/2/2 ¤W¤È 07:46:42²Ä2819½g¦^À³
Interceptªº Ocaliva[²×§½¤§¾Ô]¤W¬M¤é´ÁºV©w¡A²¼©Ð·|¦p¦ó¦P¼Ë«ø¥Ø¥H«Ý!

2023.1.19-FDA ±µ¨ü INTERCEPT ªº OCA ·sÃĥӽСA¥Î©óªvÀø NASH ¤Þ°_ªº¨xµw¤Æ«e´Á¨xÅÖºû¤Æ(PDUFA ¥Ø¼Ð¦æ°Ê¤é´Á³]©w¬°2023¦~6¤ë22¤é)

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/1/18 ¤W¤È 07:49:34²Ä 1600 ½g¦^À³

·Q[½ä]¤@©]­P´I?³o®aIntercept pharmaceuticalsªº[²×§½¤§¾Ô]¦³¼Éº¦10~20­¿ªº¹ê¤O»P¾÷·|?!

­ì¦]:

...

...

4.­Ó¤H¤£·|©ãª`³o³õ½ä§½¡A°lÂÜFDA§å­ãªº²Ä1¤äNASHÃĪ«¥Î¡C

·|­û:ROGER588910148151µoªí®É¶¡:2023/2/2 ¤W¤È 07:34:46²Ä2818½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2021/5/14 ¤W¤È 09:00:01²Ä 1121 ½g¦^À³

108/07/24 Bio-Asia¨È¬w¥Í§Þ¤j®iÁ|¿ì¤§¤½¥q®i±æ»¡©ú·|:SNP-6Àø®Ä¦w¥þ©ÊÀu©ó«eªuªºMadrigal MGL-3196¡C

¬Q¤éMadrigal¥«­È21.83»õ¬ü¤¸(³o®a¤½¥q¤]´N2¤äªvÀøNASHªºÃĪ«MGL-3196(P3) /MGL-3745(Á{§É«e)¥~¡A§OµL¥Lª«!) www.madrigalpharma.com/ourapproach/pipeline/

¥Ø«eªYÄ£¥«­È¤£¤ÎMadrigalªº10%!

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/12/22 ¤U¤È 07:13:12²Ä 2748 ½g¦^À³

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/12/21 ¤U¤È 08:39:13²Ä 2746 ½g¦^À³

¤@¥¹¦¬ÁÊ»ù¯}¦Ê»õ¡ANASHÃĪ«¦b2023¦~§óºë±m!

Speculation is already building among industry observers that the company could become a takeover target, perhaps garnering as much as $9 billion.

----------------------------------------------------------------------------------------------------

MadrigalÀ³¸Ó½æ¶Ü¡H

...µØº¸µó¦ô­p¡A³o­Ó©|¥¼¶}µoªºÃÄ«~¥«³õ¨C¦~¥i²£¥Í¶W¹L 350 »õ¬ü¤¸ªº¾P°âÃB¡C

... MDGL ¬°¤°»ò­n¥H°Ï°Ï 100 »õ¬ü¤¸ªº»ù®æ¥X°â¦Û¤v¡H

°Ï°Ï100»õ¬ü¤¸ªº»ù®æ¬O½â½æ¤F? Orz.

----------------------------------------------------------------------------------------------------

¥Ø«eMadrigal¥«­È51.58»õ¬ü¤¸¡AªYÄ£¥«­È¬OMadrigalªº5%!

«ø¥Ø¥H«Ý°ê»Ú¤j¼t·|¤£·|¶}¥X°ª©ó100»õ¬ü¤¸¦¬ÁÊMadrigal???

·|­û:¦V«e¦æ10140498µoªí®É¶¡:2023/2/1 ¤U¤È 10:09:12²Ä2817½g¦^À³
¤j®a¤@°_°Ñ¥[¤µ¦~ªºªÑªF¤j·|

¶Ê«P¤½¥q¥[§Ö¸ÕÅç³t«×

¤£ºÞ¬O810¡B610¡B630³£­n§Ö°¨¥[Ã@ªº§¹¦¨

NASH²Ä¤@¦W¶i«×¦h¦¸¯¸¤W3¦Ê¬ü¤¸

A¤½¥q2b´Á¤¤³ø§i«á³£¦b50¬ü¤¸ªþªñ±r«Þ

ÁÙ¦³«ØÄ³¨ì¨º´µ¹F§J¤W¥«

ÃĮįu¦p¤½¥q©Ò¤½§iªº¼Æ¾Ú

¦Ü¤Ö¤]­È20-30¬ü¤¸

­JP ªº²Ä¥|¡B²Ä¤­¦Wµ¦²¤¤£²Å¦X°Ó·~Ävª§¤O

©Ò¥H²{¦bªºªÑ»ù¥u¦³²Ä¤@¦Wªº¹sÀY-3¬ü¤¸

·|­û:op123410143906µoªí®É¶¡:2023/2/1 ¤U¤È 09:37:10²Ä2816½g¦^À³
·PÁ¤g¤jªº¤À¨É¡G¤T¦~«e´N¦b»¡±ÂÅv¡H±z¤S»¡¤@¦~«á¤~¥i¯à±ÂÅv¡H©Ò¥H±z­nºCºC¶R¡H·|¤£·|¦³°ÝÃD¡H

¯uªº¥Í§Þ¤½¥qÅý¤H¬Ý¤£À´¡H©Ò¥H«Ü¦h¤H³£¤£·P§ë¸ê¥Í§Þ¤½¥q¡C

·|­û:¤g¾|µf10147850µoªí®É¶¡:2023/2/1 ¤U¤È 08:48:37²Ä2815½g¦^À³
§Ú­è¶}©l¶R, ÁÙ¨S¶R¦h¤Ö±i. «Ü´Ü¨ØªO¥D2020 ´N¦b±À, ·í®ÉªÑ»ù¤~25. ·í®É¶Rªº²{¦b¤w¸g¤jÁÈ. ¤£¹L·í®É´N»¡­n½Í±ÂÅvª÷, ²{¦b¹L¤F§Ö­n3¦~¤]¨S°ÊÀR. §Ú¬Ý¥i¯àÁÙ­n1¦~. ¥i¥HºCºC¶R, ¤µ¦~­p¹º¥h°Ñ¥[ªÑªF·|.
·|­û:½²ºû¤¯10143700µoªí®É¶¡:2023/1/31 ¤U¤È 07:40:43²Ä2814½g¦^À³
¤g¤j®¥³ß±z¥[¤J¦æ¦C¡A­Y±ÂÅv®ø®§Ãn¥ú¤@¤Ñº¦´T¥i¯à¶W¹L¤@­¿¡I­Ó¤H¹ï¥Í§ÞªÑ­ì¬Oªù¥~º~¡A¦]¦U¤j¤j´£¨Ñ¦UºØ¸ê°T¡A²{¦bÁÙ¯uªºÀ´±o¦p¦ó¿ïÀu¨qªÑ²¼¡I©ñ3¦~±z¤@©w·|Àò§Qªº¡C
·|­û:¤g¾|µf10147850µoªí®É¶¡:2023/1/31 ¤U¤È 03:44:40²Ä2813½g¦^À³
§Ú¬O¹A¾ä¦~°²§â«e­±¦U¦ì¥ý¶iªº¤å³¹³£«ôŪ¤F. ·Pı¤½¥q«Ü¦³«e´º. ¥u¬O±ÂÅv¦³ÂIºC. 6919 ¥«³õ³W¼Ò¤ÎÁ{§É³£¤£¤Î6634. ¦ýªÑ»ù¤w¶W¹L200, ¥«³õ¥Ø¼Ð»ù¤]»á°ª.

§Ú²{¦b¶R¶i´N¥´ºâ«ù¦³2-3¦~.

·|­û:½²ºû¤¯10143700µoªí®É¶¡:2023/1/31 ¤U¤È 12:46:19²Ä2812½g¦^À³
¸Ô¬ãªYÄ£¤½§i¤å½g¡A¥L­Ì¦Û»{¬ãµo¶i«×»â¥ý¸s¶¯¡F¤pªÑªFı±oÀt³t¡A¦Ü¤Öªí¥Ü¤½¥q¦³ª`·N¶i«×°ÝÃD¬O¦n¨Æ¡C¤½¥q¹ï630«D±`­«µø¡A¤]§â610·í«e¶i¸Õ±´ÃÄ¡A¦]¬°610¦¨¥\©Ò¥H630¦¨¥\¾÷·|«D±`°ª¡I¥H©¹§ÚÁ`»{¬°610¤w2´Á«Ü¤[¤F­n¨«3´Á·|¥Î610¡A²{¦b·Pı±N¨Ó630¤G´Á­Y¦¨¥\¡A©¡®É­YµL¦n±ø¥ó±ÂÅv¥X¥h¥i¯àÄ~Äò¥H630¨«3´Á¡A¦]¬°¥¦¤~¬O¥D¨¤¡CÁ`»¡¥¼¨Ó³o3¦~ªYÄ£·|¦bªÑ¥«½AÀéµo¥ú¡I
·|­û:¦V«e¦æ10140498µoªí®É¶¡:2023/1/31 ¤W¤È 10:51:27²Ä2811½g¦^À³
¦pªG¬O·s¶iªÌ

©Î³\­n¬Ý¤@¤U«e¤å

¤~¯à¤F¸Ñ¡uªYÄ£¡vªº°ò¥»­±

­È¤£­È±o§ë¸ê¡I

R¤jªº´£ÂI¡G¤j¼tªº·Ð´o¡A´N¬OªYÄ£ªº¾÷·|¡C

·|­û:¤g¾|µf10147850µoªí®É¶¡:2023/1/31 ¤W¤È 09:46:03²Ä2810½g¦^À³
½Ð°Ý³o¹ïªYÄ£¬O¦nªº¼vÅT¶Ü? ©êºp¥i¯à¬O²Â°ÝÃD,ªì¶iªÌ¤£À´.
·|­û:ROGER588910148151µoªí®É¶¡:2023/1/31 ¤W¤È 08:03:19²Ä2809½g¦^À³
ªñ´ÁJ&J»PGSKªº°ª¼h·|¬Û·íÀYµh!

2023.1.11-¼Æ¥H¦Ê­pªº¡§®õ¿Õ¶D³^¡¨ÁnºÙ¹s°â°Ó¡B»s³y°Óª¾¹DÃh¥¥´Á¶¡¹ï¤A酰®ò°ò×ô¥i¯à¾É­P¦Û³¬¯g¡B¦h°Ê¯gchildrenshealthdefense.org/defender/tylenol-lawsuits-acetaminophen-pregnancy-autism-adhd/

...¹w­p±j¥Í¤½¥qÁÙ±N¦]¯A¶û¹ªÀy¦bÃh¥¥´Á¶¡¼sªx¨Ï¥Î¹ï¤A酰®ò°ò×ô¦Ó´£°_¶D³^¡A³o¥i¯à·|¨Ï³o¤@¼Æ¦r¹F¨ì¼Æ¤d¤H¡C

--------------------------------------------------------------------------------------------------

°ü¤kÃh¥¥´Á¶¡½w¸Ñ¯kµhªº¿ï¾Ü«Ü¤Ö¡AAPAP¬O¬°¼Æ¤£¦hªº³q±`³Q»{¬°¥i¥H¦bÃh¥¥´Á¶¡¦w¥þªA¥Îªº¤îµhÃĤ§¤@¡C¥¦Àu©ó«DÍrÅéÃþ§Üª¢ÃÄ (ªü¥q¤ÇªL¡B¥¬¬¥ªâ©M萘´¶¥Í)¡A«áªÌ¤w³QÃÒ©ú·|³y¦¨§³®W­·ÀI¡A¨Ò¦p¦Ï¤ô¹L¤Ö©Î­L¨àµÇŦ°ÝÃD¡C

2020.10.15-¬ü°êFDAºô­¶

www.fda.gov/drugs/drug-safety-and-availability/fda-recommends-avoiding-use-nsaids-pregnancy-20-weeks-or-later-because-they-can-result-low-amniotic

«ØÄ³¥¥°ü¦b 20 ¶g«á¤£­nªA¥Îªü¥q¤ÇªL¡B¥¬¬¥ªâ©M萘´¶¥Íµ¥«DÍrÅé§Üª¢ÃÄ¡A¦]¬°³o¥i¯à·|¾É­P¦Ï¤ô¹L¤Ö¡C

·|­û:¦V«e¦æ10140498µoªí®É¶¡:2023/1/28 ¤U¤È 02:16:24²Ä2808½g¦^À³
¬Ý®É¶¡ÂI2017¦~

¸ÕÅç¦aÂI¦b»OÆW

¸ÕÅç­p¹º¤º®e

³£»PSNP-610-201¸ÕÅç­p¹º¤º®e¬Û¦ü

¤£ª¾¹D¬°¤°»ò·|¦³SNP612ªº¦WºÙ¡H

¦Ó¥B¬O¥X²{¦b¸Ó©xºô¯¸¡I

·|­û:ROGER588910148151µoªí®É¶¡:2023/1/27 ¤U¤È 09:37:30²Ä2807½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2021/7/4 ¤W¤È 11:08:46²Ä 1281 ½g¦^À³

ÁÙ¦³1¤äSNP-612¡A²ö«D¬OSNP-630ªº³­¶ù¤XøU¡A¦a¦ì¤£­«­n?

¥xÆWÃĪ«Á{§É¸ÕÅç¸ê°T¥­¥x¬d¤£¨ìSNP-612(¤½¥qºô­¶¤]¨S³o¤ä)....

--------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2020/7/9 ¤U¤È 09:31:39²Ä 85 ½g¦^À³

SNP-630 ·|¤À¸Ñ¬° 3 ­Ó¬¡©Ê¥NÁª«¡A¨ä§@¥Î©ó NASH ¾÷Âà»P¥ÀÃĬۦü¡A±©¨äÃIJz¬¡©Ê§¡§C©ó SNP-630¡C

--------------------------------------------------------------------------------------------

SNP-630¥NÁª«:SNP-610 / SNP-612(?) /SNP-620(?)

·|­û:¾¾¹À©OÎN¹À«¡10150521µoªí®É¶¡:2023/1/26 ¤U¤È 06:06:44²Ä2806½g¦^À³
SNP-612

Recruitment Status : Terminated (recruitment difficulties due to Covid-19)

First Posted : March 11, 2019

Last Update Posted : January 6, 2023

www.clinicaltrials.gov/ct2/show/NCT03868566?term=sinew+pharma&draw=2&rank=4

·|­û:LIDOU10151855µoªí®É¶¡:2023/1/25 ¤U¤È 04:54:31²Ä2805½g¦^À³
·Q½Ð°Ý¤@¤U³Ì·s§ó·sªº810QA¦b­þ¸Ìªü

¨S¦³¬Ý¨ìªü ·PÁÂ~~

·|­û:¤p¨k¤H10151116µoªí®É¶¡:2023/1/23 ¤U¤È 07:45:28²Ä2804½g¦^À³
¤j®a·s¦~§Ö¼Ö

½Ð°Ý¦³¤Hª`·N¨ì104¦b¼x½]®Ö¥DºÞ¡A¬Ý¨Ó¥i¯à­n´«¤H¡H¬O§_¤WÂd©µ«á¾÷²v¼W¥[¡H

·|­û:Ntumgk10151447µoªí®É¶¡:2023/1/17 ¤U¤È 01:25:39²Ä2803½g¦^À³
¦X®w¦³¤@¤ÀÂI¤@ª½9±i9±i½æ¡A¬O­þ­Ó¤º³¡¤H¦bÄw¬õ¥]¿ú¶Ü¡I¯¬¦U¦ì¤j¤j·s¦~§Ö¼Ö¡A§ë¸ê¶¶§Q
·|­û:¦V«e¦æ10140498µoªí®É¶¡:2023/1/17 ¤W¤È 07:58:57²Ä2802½g¦^À³
¤½¥qºô­¶¦³ÃöªºQ&A³¡¤À¦n¹³¦³§ó·s

810®³¨ì¬ü°êOTCÃÄÃÒ«á¡A±q¥H«eªº¡u¦X§@¨óij¡v§ï¬°¡u±ÂÅv¡v¡C

¡u±ÂÅv¡v¬O§_²{¦b¥¿¦b¬¢½Í¤¤¡H

810¼Ï¶s¸ÕÅç¡A®³¨ì³B¤èñÃÄÃÒ«á­n¡u¦Û¾P¡v¡C

±ÂÅvª÷ÃBµø¥«³õ³W¼Ò¡I

610¦n¹³¨S¦³§ïÅÜ

·|­û:½²ºû¤¯10143700µoªí®É¶¡:2023/1/16 ¤U¤È 07:02:03²Ä2801½g¦^À³
¤½¥qªá¿ú«O¦u°]±±¤£¿ù¡A¬ãµoÀu¶V­È±o©ç©ç¤â¡I¦U¤j¤j¨D¦n¨D§ÖÁ¿®Ä²v¬O¥¿½T¡C§Æ±æ¦b610³¡¤À»°§Ö¨«¤W3´Á¹D¸ô¡A6¨t³¡¤À°£¤F¦³¦nªº±ÂÅv±ø¥ó¥~¡A§_«h¤£­n®ö¶O®É¶¡¡C·í6¨t¦³3´Á³q¹L±ø¥ó¡A¤]§ó±µªñÃÄÃÒ¨ú±o¡A±ÂÅv¦æ±¡Â½­¿¦Ü¤Ö25»õ¬ü¤¸¡I¦A¥[¤W8¨t2ÁûÃÄ¡AÁ`±ÂÅv¤W¬Ý40»õ¬ü¤¸¡C§ÚÁÙ¬O°í«ù¤£­n»¡¥¦·|¬OªÑ¤ý¡A©È³Q·R¥´ºjªº¤H¥´ºj¡C
·|­û:dk10140377µoªí®É¶¡:2023/1/13 ¤W¤È 10:09:42²Ä2800½g¦^À³
¬Ý¤F¤@¤U´Nºâ¤pªÑªF¥[¦b¤@°_¡AÁÙ¬OµLªk¾Ù°Ê¤jªÑªF¡C¯à·m¨ì¤@®u´N°½¯º¤F¡CÁÙ¬O¤j®a¤]¨Ó¦s·sÄ£¡C±À­Ó¥D¨Æ¤H¡C¤£µM´N¬Oª§¨ú´I¨¹Ä_¨Î¯¸¥x~~~¤µ¤Ñ³o±jªº¤j½L¤]µL¤O¤W§ð¡Agg
·|­û:¦V«e¦æ10140498µoªí®É¶¡:2023/1/12 ¤U¤È 12:40:27²Ä2799½g¦^À³
R¤j

¤£±µ¹q¸Üªº²z¥Ñ«Ü¦h¡A©Ç¤£±oªü©f¡A¦Y¤HÀY¸ô¡AÁ`­n¿í±q¦ÑÁó«ü¥Ü¡C

610¸ÕÅç¯f±w¡A·íµM­n²Å¦X¤@©w±ø¥ó¤~¯à¦¬®×¡C

¤£¹L¡A2b¦¬®×¤H¼Æ¤]¤£¦h¡A­«½à¤§¤U ¥²¦³«i¤Ò¡C

µ¹°t¦XªºÂå°|¦hÂIÃB¥~³ø¹S¡A¦¬®×³t«×·|§Ö¤@ÂI¡C

´N¬O¬Ý¥D¨ÆªÌªº·Qªk¡B°µ¬°¡A¦pªG¬O¥H°Ó¤Hªº§Q¯q¨Ó¬Ý«Ý¡AºA«×·|¿n·¥¡C

810¼Ï¶s¤H¼Æ¤]¤Ö¡A¥B¸ÕÅç¹ï¶H«D±`¦n§ä¡A¤H®aµ¹2¸U¡A¤½¥qµ¹3¸U¡A¤£¥X´X­Ó¤ë´N¥i¥H°µ§¹¡C

¥u­n¼Ï¶s¹F¼Ð¡A³B¤èñÃÄÃÒ´N««¤â¥i±o¡C

¤j¼tªº¦X§@¨óij¤£¬O§ó¦³§Q¶Ü¡H

¹D²z´N¬O³o¼Ë²³æ¡I

±z·Q¡H

ªYÄ£ªºªÑ»ùÁÙ·|¦b³o¸Ì°­²V¶Ü¡H

·|­û:ROGER588910148151µoªí®É¶¡:2023/1/12 ¤W¤È 11:29:47²Ä2798½g¦^À³
2022.10.30-ªYÄ£¤îµh·sÃĸÑÂê40¦~¨x¬r©Ê°ÝÃD °ê»Ú¤j¼t±ÂÅv¦b±æ(¦¶¸³±µ¨ü¤¤¥¡ªÀ±M³X)

¦¶³Í¥Áªí¥Ü...¦P®É±N¥[³t¯×ªÕ¨x·sÃÄSNP-610¶}µo¡A­º¥ý±NÂX¼W1­¿ªº¬ãµo¤H­û

---------------------------------------------------------------------------------------------

¬O¦³­n¥[§Ö¶}µoªº¸}¨B(±NÂX¼W1­¿ªº¬ãµo¤H­û)¡A¦ý104¤Wªº¨xŦ¯e¯f¬ãµo³B»P¯kµhÃĪ«¬ãµo³B¤w¶K¦n¤[¡A¦n¹³§ä¤£¨ì¬ÛÃö¤H­û?

·|­û:ROGER588910148151µoªí®É¶¡:2023/1/12 ¤W¤È 11:00:21²Ä2797½g¦^À³
§Ú¦b12¤ë®É¥h¹q1¦¸¡Aªü©f»¡¶}·|¤¤(¨S­n§Ú¯d¸ê®Æ)¡C

¸³¥Jªº¸¹½X¦b§Ú¤â¾÷ºLÃa´«·s®É¤£¨£¡A§Ú¤]§ä¤£¨ì¤H°Ý...

·|­û:¦V«e¦æ10140498µoªí®É¶¡:2023/1/12 ¤W¤È 10:54:48²Ä2796½g¦^À³
­Ó¤H±j¯P«ØÄ³

ªÑªF¤j·|®É´£®×

Àµ½ÐªYÄ£¨ì¬ü°ê¨º´µ¹F§J¤W¥«

¦Ü¤ÖªÑ»ù¤]¦³1-20¤¸¡A¤£·|¹³²{¦b¤~3¶ô¦h¡C

¦Ó¥B¡Aª¾¦W«×¤]¸û°ª¡I

·|­û:dk10140377µoªí®É¶¡:2023/1/12 ¤W¤È 10:45:53²Ä2795½g¦^À³
¥i¯à­nªí¥Ü¦Û¤w¬O°OªÌ¤~·|±µ¹q¸Ü¡A¤pªÑªF´N¤£ºÞ¦º¬¡¤F

³Ñ¤U3¤Ñ«ÊÃö¡A­è¦n¬OR¤j©Ò´£°¨¶³¡G¤µ¤Ñ«Ü´Ý»Å ©ú¤Ñ§ó´Ý»Å «á¤Ñ«Ü¬ü¦n ¦ý¤j³¡¤À¤H¦º¦b©ú¤Ñªº±ß¤W!!°¨¶³¤Ó½Ä°Ê´±©M²ß¤j¹ï·F¡A¤H³£®ø¥¢¡AªÑ²¼¤]®ø¥¢¡C(ÁÙ¦n°¨¶³¤£»{ÃÑ¿ú¬O¤°»ò)

µo­Ó¤j¬õ¥]§a~~~

·|­û:¦V«e¦æ10140498µoªí®É¶¡:2023/1/12 ¤W¤È 10:39:46²Ä2794½g¦^À³
R¤j

¦¶¸³®Ú¥»¤£·Q±µ¹q¸Ü

¤u·~§½ªº¦P·N¨ç´Á­­¨ì3¤ë¤U¦¯

¦pªG¶W¹L´Á­­¥¼´£¥X¤WÂd¥Ó½Ð

´N¦³±oµ¥¤F

·|­û:ROGER588910148151µoªí®É¶¡:2023/1/12 ¤W¤È 10:28:50²Ä2793½g¦^À³
2022.10.30-ªYÄ£¤îµh·sÃĸÑÂê40¦~¨x¬r©Ê°ÝÃD °ê»Ú¤j¼t±ÂÅv¦b±æ(¦¶¸³±µ¨ü¤¤¥¡ªÀ±M³X)

-----------------------------------------

³Ìªñ¦³¤H¥h¹q¤½¥q°Ý¹L±ÂÅv»P¤WÂd¶i«×¶Ü?

·|­û:ROGER588910148151µoªí®É¶¡:2023/1/12 ¤W¤È 10:21:27²Ä2792½g¦^À³
www.marketscreener.com/quote/stock/MADRIGAL-PHARMACEUTICALS-30340910/charts/

madrigal stock

2022.12.5 °ª83¤¸¡A7±þ¨ì2022.12.14§C57.21(¦¬58.39)¡A3¤Ñ«áªº¶g¤@2022.12.19¤jÃzº¦!

-----------------------------------------------------------------------------------------------------

°¨¶³¡G¤µ¤Ñ«Ü´Ý»Å ©ú¤Ñ§ó´Ý»Å «á¤Ñ«Ü¬ü¦n ¦ý¤j³¡¤À¤H¦º¦b©ú¤Ñªº±ß¤W

·|­û:dk10140377µoªí®É¶¡:2023/1/12 ¤W¤È 09:41:53²Ä2791½g¦^À³
¤@¼Ë³£¬O¸ê¥»¥«³õ­nÁÈ¿ú¡A¦Ñ¸Ü¤@¥y­n¤£­nª£¦Ó¤x~

­Js¾Ç³N¤W¬O¼·¡¡A¦ý§ë¸ê´N¤£¤@©w¤F(¤½¥q¤]¨Sµ¹¥LªÑ²¼¡A¦Û¤w¦³¨S¦³¶R´N¤£ª¾¹D¤F)¡A§Úı±o¤ßµ|¤]¬O°]°È¤Wªº°ÝÃD³y¦¨¤µ¤éªº§½­±¡A¦ý¤£±Æ°£¬O¥D¤O³Î­´µæ¡C

·sÄ£¤µ¤Ñ¤S¯}¦Ê¤F@@¡C«á¨Ó°l¦^ªº¤S®M¤F¡C½u«¬¤W¤]¤£¨Î¡C

¥Í§Þ³oªi¥»¨Ó´N®z¡A¦X¤@¤]gg¡C¤T­Ó¤ë¤S¤T­Ó¤ë¡A¨C¦¸·s»D¤j¶i«×¤p¡C

·|­û:¦V«e¦æ10140498µoªí®É¶¡:2023/1/12 ¤W¤È 08:52:06²Ä2790½g¦^À³
¦pªG§Ú¨S¦³°O¿ùªº¸Ü

¤½¥q¦~³ø¦³Madrigal ªº3´Á­n¨ì2024¦~

¤H®a¦b¥h¦~2022¦~©³¤½¥¬3´Á¡A¬Ý¬Ý¤H®aªº¿n·¥ºA«×¡C

¦A¬Ý¬ÝªYÄ£ªºÀt¨B°µªk¡A¤j®a¤@°_¶Ê«P¤½¥q¥[§Ö¸ÕÅç³t«×¡C

¥ú¬O¼Ï¶s¸ÕÅç¤~´X¤Q¤H¡A¥l¶Ò¸ÕÅç¹ï¶H¨C¤Hµ¹3¸U¬ü¤¸¡C

¾a¸y¡A¨S´X­Ó¤ë´N°µ§¹¤F¡AÁÙ·d¨º麽¤[¡H

·|­û:¤p¨k¤H10151116µoªí®É¶¡:2023/1/12 ¤W¤È 08:47:08²Ä2789½g¦^À³
º¡»{¦P¦V¤jªº·Qªk¡K

¨ä¹ê¤ÏÆ[2022¦~¡A¤j½L¥­§¡³£¬O-20%¡K§ë¸ê¬üªÑ§ó¬O-40%

¦p¦P½²¤j»¡ªº¡K ¥H¼W¸ê»ù75¶ô¨Ó¬Ý¡K¾ã¦~ÁZ®ÄÁÙ¬O+20¥H¤W¡K ¨S±o¬D¤F

·sÃħë¸ê§Ú¬O©ê«ùµÛ¥H¦~¬°³æ¦ì¡K3-5¦~°ò¥»ªº¡K®M¥y¸ô¸³»¡ªº¡K¤Q¦~¿i¤@¼C¡A»P¤j®a¦@«j

·|­û:¦V«e¦æ10140498µoªí®É¶¡:2023/1/12 ¤W¤È 08:13:55²Ä2788½g¦^À³
­Ó¤H¬Ýªk¡A¶È¨Ñ°Ñ¦Ò¡I

¤îµhÃÄ¥«³õ¬OÃe¤j¡A¦ý¤p¼t¦æ¾P¬O«Ü§xÃøªº¡C

¤j¼t¦³°ªª¾¦W«×¡A¦³Ãe¤jªº³q¸ô¡C

´N®³³o¦¸¡u´¶®³¯k¡v¤§¶Ã¨Ó»¡¡A®Ú¥»¤£¯Ê¤AñQÓi×ôªºÃÄ¡C

¦ý¤j²³¥u»{¡u´¶®³¯k¡v¡I

»P¤j¼t¦X§@¤~¬O³Ì¨Î¿ï¾Ü¡I

³B¤èñªºÃÄÃÒ³\¥i¡A¤À¼í·|¸û°ª¡C

¦ý¬O¡A¤½¥q¸ÕÅç¶i«×¹³¯QÀt¤@¼ËºCºCºCºCºCºC¨ì¤£¦æ¡I

NASH¤]¬O¤@­Ó¼Ë¡AºC¨ì¤£¦æ¡C

­Ó¤H«D±`¤£»{¦P­J±Ð±Âªº·Qªk¡A¤£·m²Ä¤@¡A¦Ñ¥|¡B¦Ñ¤­³£¦æ¡C

§L¶Q¯«³t¡A¾ÇªÌ»P°Ó¤Hªº·Qªk¡B°µªk³£¤£¦P¡C

¤µ¤Ñ¦pªGªYÄ£NASH2b¤w§¹¦¨¡AªÑ»ù¦­´N¥h°lAkero ¤F¡C

²{¦bªº²Ä¤@¦WMadrigal ªÑ»ù£¸ª½¬D¾Ô3¦Ê¬ü¤¸

³o´N¬O²Ä¤@¸ò·Q·í¦Ñ¤­ªº®t§O

·|­û:dk10140377µoªí®É¶¡:2023/1/11 ¤U¤È 09:20:36²Ä2787½g¦^À³
¤T­Ó¤ë¹L¥h¤F¡A¤S­±Á{¦Ê¤¸«O½Ã¾Ô

³oOTC¯uªº¤£¤Ó­»¡A¥[¤WµL¬r¡A¥D¤O¬Ý¤£¤W~~

========================================================================

³£¦³³\¥i¤F ÁÙ¤£­»¶Ü?

¨ì©³¦bµ¥¤°»ò ¥xªÑ¬P´Á¤@¤S­n³Q¬üªÑ¸õ¤ô¼v¦V ¤pģģ·|¤£·|¶^¯}120©O??

=============================================

¦³¤@¨Æ¤@ª½¤£¸Ñ¡G¸³¨Æªøªí¥Ü¡A¸Ó¤½¥q¶}µoªºµL¨x¬r©Ê¤AñQÓi×ô¤îµh·sÃÄSNP-810¡AÀò¬ü°êOTC ³\¥i¡A¤w¨ú±oNational Drug Code¡]°ê®aÃÄ«~ÅçÃÒ¸¹¡^¤Î¬ü°ê¥«³õ¾P°â¸ê®æ¡C

¤jÃļt±ÂÅvª÷°ª¡A¾P°â¶q¤j¤S¯à°¨¤W¥Î­ì¨ÓÃÄÃÒÄ~Äò¾P°â¡Aµ¥·sÃÒ¤U¨Ó¦A´«ÃÒ¡A¤À¼íª÷¤]°¨¤W¦³¡A³o¬O¤½¥q±ÂÅv­º¿ï²{¦b¦X§@¤j¼t­ì¦]¡F¬Û«H©¼¦¹¦X§@¨Ã¥BÂX¤j¦X§@¤~¬OºÍ´¼¡C

·|­û:´MÄ_10151381µoªí®É¶¡:2023/1/11 ¤W¤È 10:43:26²Ä2786½g¦^À³
¬JµM¤½¥qªº¤îµhÃĤw³q¹L¢Ô¢Ò¢Ïªº¢Ý¢â¢Ñ¡A¦A¥[¤W¤£¶Ë¨x¡A¬°¦ó¤£¥ý·m¦û¢Ý¢â¢Ñ¥«¦û¬J¥i°^Äm¬ãµo¸g¶O¤S¥iµ¹°ê»Ú¤jÃļtÀ£¤O¡A«o¦b­W­Wµ¥«Ý±ÂÅv¡A°Ó¾÷¬O¤£«Ý¤Hªº¡A¤@¥¹³Q¨ä¥L°ê»ÚÃļt°l¤W¶i«×¡A³oÁû¤îµhÃĪº»ù­È´N¤@¸¨¤d¤V¡A³o©Î³\¤]¬O°ê»Ú¤jÃļt¥H©ì«ÝÅܪºµ¦²¤¤§¤@¡C

¥t¥~¡A¤£ª¾¹D¤j®a¦³¨S¦³µo²{¡A¥«³õ¦b½Í½×·sÃĶ}µo©Î±ÂÅv¶i«×®É¡A´X¥G«Ü¤Ö½ÍÈЪYÄ£ÈСA­ì¦]¬O¤°»ò¡H¤£¬Ý¦n¶Ü?

·|­û:½²ºû¤¯10143700µoªí®É¶¡:2023/1/5 ¤U¤È 02:04:58²Ä2785½g¦^À³
madrigalªºnash¥N¸¹mgl3196¡C²ºÙ3196¤ñ«¥610¤G´Á¼Æ¾Ú®t¡A¡q610¼Æ¾Ú¬O²Ä¤@¦W¡r¦]¤G´Á­n±ÂÅv¥X¥h»ù¦ì¤£²z·Q¡Aªá¤£¦hªº¿ú³q¹L¤T´Á¡A²{¦b¦æ±¡°ª¥X100»õ¬ü¤¸¥«­È¡I«e­±¦³³o¸ê®Æ¬Or¤j¶Kªº¤å¡C¸É­z¡C
§Ú­n¦^À³¥»¸ÜÃD
·|­û:
§@ªÌ:
¬ÛÃöªÑ²¼¤½¥q¦WºÙ:ªYÄ£¥ÍÂå
¤º®e:
½Ð¥ýµn¤J­Y±z©|µL·|­û¨­¤À¡A½Ð¥ý¥Ó½Ð±b¸¹
°Q½×°Ï¬ÛÃö³W©w¡G
1.­Y±b¸¹¶¢¸m¹L¤[¨t²Î·|¦Û°Êµn¥X¡A«ØÄ³¦b¼g¦n¤å³¹¨Ã¥B©|¥¼µo°e¤§«e¥ý¦æ½Æ»s¡A¥H§Kµo°e¥¢±Ñ«á¾É­P¤º¤å®ø¥¢¡I
2.½Ð¤Å°Q½×ªÑ²¼¶R½æ©Î´£¤Î¦¨¥æ»ù¦ìµ¥¨Æ©y¡A¤Z¬O¯d¤U¬ÛÃö¥æ©ö°T®§¡A¥»ºô±N¦Û°Ê§R°£¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
3.ÄY¸T¯d¤UÁpµ¸¤è¦¡¡A½Ñ¦pLINE¡BFB¡BE-mail¡B¹q¸Ü..µ¥¡A©Î¥H¥ô¦ó©ú¥Ü¡B·t¥Üµ¥¤âªk¶i¦æÁpµ¸¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
4.¬°Á×§K®ö¶Oºô¸ô¸ê·½¡A½Ð¤Å±N¬Û¦P¤º®e³sÄòµo¦b¦h­Ó¤£¦P¥DÃD¤º¡A©ÎªÌ³sÄòµo°e¦h­Ó·s¥DÃD¡A­Y¦³¦¹Ãþ¬~ª©¤§¦æ¬°±NµLªkÄ~Äò°Ñ»P°Q½×¡I
5.ÄY¸T·N¹ÏÂǥΥ»ºô¥­¥x¤½µM´²¥¬¤å¦r©ó²³¡A¦Ó«üÂÖ¡B«V°d©Î¶Ç­z¨¬¥H·´·l¥L¤H¦WÅA¤§¨ÆªÌ¡A­Y¦]¦Ó¯A¤Îªk«ß°ÝÃD¡A·§»P¥»¤½¥qµLÃö¡A·q½Ð¿í¦u¡C

·q½Ð´L­«¥»ºô¤§¸gÀç²z©À¨Ã¿í¦uª©³W¡AÁÂÁ¡C

¼s§i¦X§@ ¥¼¤W¥«ÂdªÑ²¼¬d¸ß ¥¼¤W¥«ºô¯¸¾ÉÄý ¥¼¤W¥«ÂdªÑ²¼±MÃD ¿³ÂdªÑ²¼±MÃD ¥¼¤W¥«ªÑ²¼-¶°¹Î¤ÀÃþ ²§·~Âà§ë¸ê¥Í§Þ·~ ¤U³æ±Ð¾Ç
¥¼¤W¥«|¥¼¤W¥«ªÑ²¼|³Ì±M·~ªº  ¥xÆW¥¼¤W¥«ªÑ²¼  °]¸gºô¯¸-Copyright©2022¡£¥²´Iºô¡¤ §K¥I¶OªA°È±M½u:0800-035-178 ªA°È«H½c:postmaster@berich.com.tw
¥»ºô¯¸¬° ¥¼¤W¥«ÂdªÑ²¼¬d¸ß,¥¼¤W¥«ªÑ²¼§Y®É·s»D,¥¼¤W¥«¤½¥q¤½§i,¿³ÂdªÑ²¼¶R½æ,·Ç¤W¥«ªÑ²¼,¤¤ÅҪѬÛÃö¸ê°T¤À¨É¥æ¬yªÀ¸sºô¯¸,¸ê®Æ¶È¨Ñ°Ñ¦Ò,¨Ï¥ÎªÌ½Ð¦Û¦æ·r°u!
¥»ºô¯¸¤£¤¶¤J·|­û¶¡¤§¥¼¤W¥«ªÑ²¼¶R½æ,³æ¯Â´£¨Ñ¥¼¤W¥«ªÑ²¼¦æ±¡,«ùªÑÂàÅý,¥¼¤W¥«ªÑ²¼¹L¤á¿Ô¸ß¶È´£¨Ñ¥¼¤W¥«ªÑ²¼¥æ©ö¥­¥xµ¹·|­û¨Ï¥Î,¨Ì¥»¸ê®Æ¥æ©ö«á¬ÕÁ«¦Û­t!